查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球手术缝合线市场 - 2023-2030 年
市场调查报告书
商品编码
1316302

全球手术缝合线市场 - 2023-2030 年

Global Surgical Sutures Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球外科缝合线市场规模达到 43 亿美元，预计到 2030 年将实现 69 亿美元的丰厚增长。在预测期内（2023-2030 年），全球手术缝合线市场预计将呈现 6.2% 的复合年增长率。

手术缝合线是一种医用线，用于在受伤后结扎血管和修复受损组织。可使用丝绸等天然纤维以及尼龙和聚酯等合成材料。它们具有无与伦比的拉伸强度、柔韧性、无菌性和打结安全性。

根据手术的需要，它们有各种尺寸、类型、形式和线材料可供选择。目前有几家生产商提供合成单丝聚二氧杂蒽酮缝合线（PDS），这种缝合线广泛用于治疗软组织伤口和儿科心脏手术中的腹部缝合。

市场动态

手术数量的增加将推动市场增长

随着病人手术数量的增加，医疗行业对手术缝合线的需求也在增加。随着医疗保健行业的发展，治疗方法也在不断改进，这可能会促进市场的增长。

例如，根据 NLM 的数据，全球每年约有 4000 万至 5000 万例大型手术在美国进行，2000 万例在欧洲进行。预计其中有 1-4% 的患者可能会死亡，15% 的患者会出现严重的术后并发症，5-15% 的患者会在 30 天内再次入院。全球每年约有 800 万患者死于大手术，与心血管疾病、中风、癌症和意外事故等主要死因不相上下。

引进先进技术设备推动市场增长

人们对先进手术治疗的认识不断提高，迫使市场参与者高度重视研发工作，并向市场推出创新产品。此外，不断涌现的新型改良自动缝合器也使全球外科医生越来越青睐这些设备。

例如，2021 年 3 月 3 日，Origami Surgical 公司宣布其下一个技术平台获得批准，该平台将为外科医生提供更多的 StitchKit 设备，以适应他们各自的机器人辅助缝合要求。在单个 StitchKit 设备中，新平台可提供各种可吸收和不可吸收缝合材料。因此，上述因素有助于扩大市场。

手术缝合线的不良影响将阻碍市场增长

手术缝合会在皮肤或组织上造成穿刺伤口，从而增加感染风险。细菌可通过缝合部位进入人体，引起局部或全身感染。正确的无菌技术和术后护理是将这种风险降至最低的关键。

有些人可能会对缝合材料产生过敏或炎症反应。这可能会导致伤口发红、肿胀、疼痛或延迟愈合。对于已知有过敏反应的患者，可能需要使用其他材料制成的缝合线或选择可吸收缝合线。因此，手术缝合线的影响将阻碍市场增长。

COVID-19 影响分析

由于为防止 COVID-19 的传播，世界各地都限制了普通外科手术的手术时间，因此该流行病对外科缝合线行业产生了不利影响。此外，由于缺乏关键员工，世界各地多家医院关闭了多个科室，从而减少了向非 COVID-19 患者提供的手术建议数量。

此外，COVID-19 患者预计将急于投入关键资源进行治疗。世界各地的人们因此被迫推迟选择性治疗。此外，普通外科手术的减少也对外科缝合线市场产生了负面影响。

俄乌战争影响分析

据估计，俄乌冲突对全球外科缝合线市场的影响不大，原因是该地区的主要市场参与者较少。不过，在预测期内，原材料进出口对全球手术缝合线市场增长的影响预计不大。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第3章：执行摘要

  • 按产品类型分類的片段
  • 按应用分類的片段
  • 按最终用户划分
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 事故数量增加
    • 限制因素
      • 对先进伤口闭合替代品的需求不断增长
    • 机会
      • 新兴市场患者人数增长
    • 影响分析

第 5 章：行业分析

  • 波特五力分析法
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第7章：按产品类型划分

  • 可吸收
  • 不可吸收

第8章：按应用分类

  • 心血管
  • 一般应用
  • 妇科
  • 骨科
  • 眼科
  • 其他手术

第 9 章：按最终用户分类

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他

第 10 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
      • 亚太其他地区
  • 中东和非洲
    • 特定地区的主要动态

第 11 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十二章 ：公司简介

  • Ethicon, Inc
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Medtronic plc
  • B.Braun Melsungen AG
  • Smith& Nephew plc
  • Boston Scientific Corporation
  • Peters Surgical
  • DemeTECH Corporation
  • Internacional Farmaceutica
  • Sutures India
  • Integra Lifesciences.

第 13 章 ：附录

简介目录
Product Code: HOS1500

Market Overview

The global surgical sutures market reached US$ 4.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.9 billion by 2030. The global surgical sutures market is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030).

Surgical sutures are medical strands or threads that are used after an injury to ligate blood vessels and repair damaged tissues together. Natural fibres such as silk are used, as are synthetic materials like as nylon and polyester. They have tensile strength, flexibility, sterility, and knot security that are unrivalled.

Depending on the surgery, they are readily accessible in a variety of sizes, types, forms, and thread materials. Several manufacturers are currently offering synthetic monofilament polydioxanone sutures (PDS), which are widely used in the treatment of soft-tissue wounds and abdominal closures during paediatric cardiac operations.

MarketDynamics

Increase in the Number of Surgeries Will Drive the Market Growth

As the number of surgical procedures done on patients increases, so does the demand for surgical sutures in the medical industry. As a result of improvements in the healthcare business, improved treatment approaches are being created, which is likely to enhance market growth.

For instance, according to NLM, globally, every year, around 40 to 50 million major procedures are performed in the United States and 20 million in Europe. It is expected that 1-4% of these patients may die, up to 15% will experience severe postoperative morbidity, and 5-15% will be readmitted within 30 days. With an annual global mortality rate of roughly 8 million patients, major surgery is on par with the top causes of death, which include cardiovascular disease and stroke, cancer, and accident.

Introduction of Technologically Advanced Devices to Drive the Market Growth

Growing awareness of advanced surgical treatments is forcing market participants to place a high emphasis on R&D and to introduce new and innovative goods to the market. Furthermore, the increasing influx of new and improved automated sutures has resulted in a growing preference for these devices among surgeons worldwide.

For instance, March 03, 2021, Origami Surgical has announced the approval of its next technology platform, which will enable surgeons with additional StitchKit devices adapted to their individual robotic-assisted suturing requirements. Within a single StitchKit device, the new platform offers a variety of absorbable and non-absorbable suture materials. As a result, the aforementioned factors contribute to market expansion.

Adverse Effects of Surgical Sutures will Hamper the Market Growth

Surgical sutures create puncture wounds in the skin or tissues, which can increase the risk of infection. Bacteria can enter the body through the suture site and cause localized or systemic infections. Proper sterile technique and post-operative care are crucial to minimize this risk.

Some individuals may experience an allergic or inflammatory reaction to the suture material. This can lead to redness, swelling, pain, or delayed wound healing. Using sutures made from alternative materials or opting for absorbable sutures may be necessary for individuals with known sensitivities. Thus effects of surgical suture will hamper the market growth.

COVID-19 Impact Analysis

Due to restrictions put on general surgical procedure operating hours around the world to prevent the spread of COVID-19, the pandemic has had a detrimental impact on the surgical suture sector. Furthermore, the closure of multiple departments at various hospitals throughout the world due to a lack of critical staff has reduced the number of procedures advised to non-COVID-19 patients.

Furthermore, COVID-19 patients are expected to rush to commit critical resources to their care. People all across the world have been forced to postpone elective treatments as a result of this. Furthermore, fewer general surgical procedures have a negative influence on the market for surgical sutures.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global surgical sutures market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global Surgical Suturesmarket growth over the forecast period.

Segment Analysis

The global surgical sutures market is segmented based on infection product type, application, end user and region.

Orthopaedic surgery Type Segment Accounts for 28.3% of Market Share

The orthopaedic surgery segment is expected to expand and ankle and foot fractures are among the most common types of injuries treated by orthopaedic teams around the world. Suture materials used in orthopaedic surgery are used to close wounds and heal fascia, muscles, tendons, ligaments, joint capsules, and cerclage or tension band of certain fractures.

The rise of accidents will helps to drive the market growth. For instance, according to CDC, every year, 1.35 million people are killed on the world's roads. Every day, about 3,700 people are killed in automobile, bus, motorcycle, bicycle, truck, or pedestrian accidents around the world. Pedestrians, motorcyclists, and cyclists account for more than half of those fatalities.

These rising numbers of injuries mostly contribute to soft tissue injury, particularly tendons, creating a need for more orthopaedic closure procedures. As a result, the orthopaedic surgery category is predicted to increase rapidly throughout the projection period.

Geographical Analysis

Asia Pacific Accounted for Approximately 25.7% of the Market Share

Due to increased activity by leading market players in the region's countries. For instance, on January 4, 2023, MiMedx Group, Inc., a pioneer and industry leader in placental biologics, struck into an exclusive distribution deal with Gunze Medical Limited, a branch of Gunze Limited, for the sale of EPIFIX in Japan. Gunze Medical is a well-known manufacturer of bioabsorbable devices and materials, such as sutures and sheet products, used in a variety of surgical and wound care settings.

In addition to a nationwide network of over 90 sales representatives and clinical support personnel, the organisation has strong relationships with current clinicians. Thus above factors shows the growth of the region.

Competitive Landscape

The major global players in the surgical sutures market: Ethicon, Inc, Medtronic plc, B.Braun Melsungen AG, Smith& Nephew plc, Boston Scientific Corporation, Peters Surgical, DemeTECH Corporation, Internacional Farmaceutica, Sutures India, Integra Lifesciences and among others.

Why Purchase the Report?

  • To visualize the global surgical sutures market segmentation based on product type, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of surgical sutures market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global surgical sutures market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the number of accidents
      • 4.1.1.2. Introduction of technologically advanced devices
    • 4.1.2. Restraints
      • 4.1.2.1. Growing demand for advanced wound closure alternatives
    • 4.1.3. Opportunity
      • 4.1.3.1. Growing patient population in emerging markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Absorbable*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-Absorbable

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. General
  • 8.4. Gynecological
  • 8.5. Orthopedic
  • 8.6. Ophthalmic
  • 8.7. Other Surgeries

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Ethicon, Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Medtronic plc
  • 12.3. B.Braun Melsungen AG
  • 12.4. Smith& Nephew plc
  • 12.5. Boston Scientific Corporation
  • 12.6. Peters Surgical
  • 12.7. DemeTECH Corporation
  • 12.8. Internacional Farmaceutica
  • 12.9. Sutures India
  • 12.10. Integra Lifesciences.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us